Officials in Delhi have been urged to find more sites for cremations as the city's morgues and crematoriums are overwhelmed by masses of Covid deaths.
Read More | Lire La SuiteChina’s vaccine diplomacy stumbles in Southeast Asia
In May last year, at the height of the COVID-19 pandemic, Chinese President Xi Jinping declared that his country would soon provide safe and effective vaccines as a “global public good”, especially to the developing world.
Read More | Lire La SuiteEn Allemagne, comment Marburg est devenue « BioNTech City »
Elle accueille le plus important des trois centres de fabrication du vaccin Pfizer-BioNtech en Allemagne, qui doit produire 250 millions de doses au cours du premier semestre, 750 millions d’ici à un an.
Read More | Lire La SuiteGermany, France, Italy and Spain halt use of AstraZeneca vaccine
Suspensions follow reports that some people developed blood clots after receiving the shot, but the WHO and the EMA say they have seen no evidence of a link.
Read More | Lire La SuiteA call for global vaccine justice
The global COVID-19 vaccine roll-out is creating a “vaccine apartheid”. As of February 24, approximately 216 million people have been vaccinated against COVID-19 globally. Only 8.4 percent of these are in low and lower-middle-income countries, which are home to nearly half of the world’s population.
Read More | Lire La SuiteAfrique du Sud : vous avez dit casse-tête vaccinal ?
INQUIÉTUDE. Après avoir choisi le vaccin Johnson & Johnson, l’Afrique du Sud se dit prête à revendre ses doses d’AstraZeneca, retardant un peu plus sa campagne.
Read More | Lire La SuiteSouth Africa in shock after AstraZeneca vaccine rollout halted
South Africa's decision to halt its rollout of the Oxford-AstraZeneca vaccine after a study showed "disappointing" results against its new Covid-19 variant may have left the nation in shock, but it also shows how scientists are at the forefront of the battle against coronavirus.
Read More | Lire La SuiteLe régulateur européen approuve le vaccin AstraZeneca pour les plus de 18 ans
L'Agence européenne des médicaments (EMA) a recommandé, vendredi, d'accorder une autorisation de mise sur le marché du vaccin d'AstraZeneca contre le Covid-19 pour les personnes âgées de 18 ans et plus. Il s'agit du troisième vaccin contre le Covid-19 dont l'EMA a recommandé l'autorisation.
Read More | Lire La SuiteBritain and EU clash over claims to UK-produced Covid vaccine
Britain is on a collision course with the EU over vaccine shortages after Brussels refused to accept that people in the UK have first claim on Oxford/AstraZeneca doses produced in local plants.
Read More | Lire La SuiteCe que l’on sait de la sûreté des vaccins à ARN messager
Bien qu’étudiés depuis longtemps, les vaccins à ARN ont atteint une maturité technique plutôt récente, ce qui soulève craintes et questionnements.
Read More | Lire La Suite